Galician vaccination against respiratory syncytial virus generates admiration in the United Kingdom La Voz de Galicia
Sociedad
The voice
Writing
Pediatrician, researcher and WHO collaborator Thomas Christie praises the success of the campaign in the community with data
02 Dec 2023. Updated at 8:37 p.m.
“As the rest of the world deliberates over the logistics of introducing maternal immunization against VRSo nirsivamab (a long-lasting monoclonal anti-RSV antibody) Galicia, in the northwest of Spain, has decided to administer nirsevimab to all newborns,” the pediatrician at the Royal Hospital for Children and Young People in Edinburgh and professor wrote in his X account. from the university of this same Scottish city Thomas Christie Williams.
Aside from the campaign itself, Christie, who collaborates with the Global Respiratory Syncytial Virus Surveillance Program at the World Health Organization, what really impresses him is Sergas’ commitment “to publish its data almost in real time.” And from this data what draws your attention is the level of adherence, which is very high. “We must make sure we learn from the Galicians how they encouraged parents/caregivers to decide to protect their newborns,” says the specialist, who is also part of the MRC Institute of Genetics and Cancer.
Although he is cautious and says that we will have to wait until the end of the season to verify the level of effectiveness, he points out that there is already some data that suggests that “nirsevimab shows effectiveness in a real-world environment.” The hospitalization rates, mainly for bronchiolitis, of babies aged zero to six months, who receive the antibody, are lower than those of the group aged one to four years, to whom it is not administered.
“Nirsevimab is a costly intervention but data from trials and now from a real-world setting suggest that reducing the burden of RSV is a real possibility. “Now we need to find ways to introduce these interventions in a way that benefits those most at risk,” concludes the British doctor.
Your colleague Theodore Lytras, Professor of Public Health at the University of Cyprus, seconds Christie’s words. “Very impressive findings after the launch of passive immunization against RSV with nirsevimab to all newborns in Galicia, Spain,” the doctor published in X in reference to the Scottish pediatrician’s comments.
Filed under:WHO Sergas Scotland Vaccination Bronchiolitis
2023-12-02 17:33:30
#Galician #vaccination #respiratory #syncytial #virus #generates #admiration #United #Kingdom #Voz #Galicia
